Evaluation of the Anticancer Activity of a Bile Acid-Dihydroartemisinin Hybrid Ursodeoxycholic-Dihydroartemisinin in Hepatocellular Carcinoma Cells

• Main Authors: Tzu-En Huang (Author), Yi-Ning Deng (Author), Jui-Ling Hsu (Author), Wohn-Jenn Leu (Author), Elena Marchesi (Author), Massimo L. Capobianco (Author), Paolo Marchetti (Author), Maria Luisa Navacchia (Author), Jih-Hwa Guh (Author), Daniela Perrone (Author), Lih-Ching Hsu (Author)
• Format: Book
• Published: Frontiers Media S.A., 2020-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Hepatocellular carcinoma (HCC) is the most common primary liver malignancy in adults and accounts for 85-90% of all primary liver cancer. Based on the estimation by the International Agency for Research on Cancer in 2018, liver cancer is the fourth leading cause of cancer death globally. Dihydroarte...